Polytopic fractional delivery of an HIV vaccine alters cellular responses and results in increased epitope breadth in a phase 1 randomized trial.

MLA

Miner, Maurine D., et al. “Polytopic Fractional Delivery of an HIV Vaccine Alters Cellular Responses and Results in Increased Epitope Breadth in a Phase 1 Randomized Trial.” EBioMedicine, vol. 100, Feb. 2024, p. 104987. EBSCOhost, https://doi.org/10.1016/j.ebiom.2024.104987.

APA

Miner, M. D., deCamp, A., Grunenberg, N., De Rosa, S. C., Fiore-Gartland, A., Bar, K., Spearman, P., Allen, M., Yu, P.-C., Manso, B., Frahm, N., Kalams, S., Baden, L., Keefer, M. C., Scott, H. M., Novak, R., Van Tieu, H., Tomaras, G. D., Kublin, J. G., … Frank, I. (2024). Polytopic fractional delivery of an HIV vaccine alters cellular responses and results in increased epitope breadth in a phase 1 randomized trial. EBioMedicine, 100, 104987. https://doi.org/10.1016/j.ebiom.2024.104987

Chicago

Miner, Maurine D, Allan deCamp, Nicole Grunenberg, Stephen C De Rosa, Andrew Fiore-Gartland, Katherine Bar, Paul Spearman, et al. 2024. “Polytopic Fractional Delivery of an HIV Vaccine Alters Cellular Responses and Results in Increased Epitope Breadth in a Phase 1 Randomized Trial.” EBioMedicine 100 (February): 104987. doi:10.1016/j.ebiom.2024.104987.